Abstract 4039: Deletion of peroxiredoxin 3 (PRX3) impairs mitochondrial bioenergetics and tumor growth in mesothelioma, supporting the first in human clinical testing of the PRX3 inhibitor RSO-021
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Victoria Gibson, Joanna Dzialo, Charlotte Poile, Jan Rogel, Aida Habibovic, Kelly Butnor, Sean Duloo, James Spicer, Dean Anthony Fennell, Brian Cunniff
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148812667
Cites:
Cited by:
Related to: